Bio Green Med Solution Inc
bgmsglobal.comWhat Do They Do?
Supplies fire safety equipment, fire-resistant doors and protective apparel to businesses, government agencies and individuals.
10-K for FY2025, filed Mar 30, 2026Following our sale of Plogo and the closing of the Transaction on September 12, 2025, we now specialize in the supply and trading of…View ↗
We supply fire-resistant doors under the “PYRODOR” brand, offering one-hour and two-hour fire resistance, along with components like…View ↗
Safety ApparelView ↗
Commercial and Industrial: Developers and facility managers procure our fire extinguishers and PYRODOR doors for projects like offices and…View ↗
Government Agencies: Public sector clients source certified fire equipment for compliance with BOMBA and SIRIM/SOH standards.View ↗
Retail Consumers: Individual buyers access our safety apparel via e-commerce platforms like Shopee for home and vehicle use.View ↗
Who Are Their Customers?
Municipalities, fire contractors, distributors and individuals are direct buyers; the company also reaches customers through e-commerce platforms and wholesaler and authorized-distributor partnerships.
10-K for FY2025, filed Mar 30, 2026All products are sold directly to customers (e.g., municipalities, fire contractors, distributors and individuals).View ↗
Broad Distribution Network: Our use of e-commerce platforms, combined with partnerships with wholesalers and authorized distributors…View ↗
Retail Consumers: Individual buyers access our safety apparel via e-commerce platforms like Shopee for home and vehicle use.View ↗
How Are They Changing?
-
Jun 4, 2026
Agreed to bring Future NRG into BGMS
The proposed exchange would make Future NRG a wholly owned subsidiary, subject to shareholder approvals and other closing conditions.
Sources
8-K, filed Jun 4, 2026
On June 4, 2026, Bio Green Med Solution, Inc., a Delaware corporation (the “Company”), Future NRG Sdn. Bhd., a Malaysia private limited…View ↗
-
May 14, 2026
BGMS preferred stock was delisted
The delisting did not affect the company's common stock.
Sources
8-K, filed May 14, 2026
In March, trading of the Company’s 6% Convertible Exchangeable Preferred Stock (listed on The Nasdaq Capital Market under the symbol…View ↗
From drug development to fire safety
The older report describes a clinical-stage biopharmaceutical company developing cancer medicines and seeking partnerships for drug candidates. The latest report describes a supplier and distributor of protective and fire safety equipment.
10-K for FY2022, filed Mar 8, 2023 10-K for FY2025, filed Mar 30, 2026We are a clinical-stage biopharmaceutical company working to develop innovative cancer medicines based on cell cycle, transcriptional…View ↗
The transcriptional regulation program is evaluating fadraciclib, a CDK2/9 inhibitor, in solid tumors and hematological malignancies. The…View ↗
We have retained rights to commercialize our clinical development candidates and our business objective is to enter into selective…View ↗
Following our sale of Plogo and the closing of the Transaction on September 12, 2025, we now specialize in the supply and trading of…View ↗
Who Do They Compete With?
Competes with 3M, Dupont, and Daletec
10-K for FY2025, filed Mar 30, 2026International Brands: Global manufacturers with established names in fire safety and PPE, such as 3M, Dupont and Daletec, compete in…View ↗
Loading...
